麻酔および喉頭マスク市場：セグメント別規模、シェア、法規制、償還、手技、2033年までの予測

COPDなどの呼吸器疾患に罹患している大規模な高齢者人口ベースが市場の主要促進要因です。国連は、60歳以上の人口が2050年には20億人に達し、毎年約3%の成長率で、人口全体よりもかなり速く成長すると予測しています（UNDESA, 2017）。人口の高齢化は健康とヘルスケアに影響を及ぼし、医療機器はヘルスケア提供の重要な要素です。

また、喫煙や空気の質の低下により、COPDの世界人口は拡大し続けています。世界中で2億人以上のCOPD患者がいると推定され、そのうち6,500万人以上が中等度から重度のCOPD患者です。COPDは世界的に死因の第3位となっています。麻酔および喉頭マスクは、急性および慢性呼吸器疾患の治療領域と大きく関わっています。ある研究では、COPD患者に長期非侵襲的人工呼吸を使用した場合、死亡リスクが相対的に60％以上減少することが示されています。

COPD患者数の増加により、急性期病院市場と在宅医療市場の規模が拡大しています。麻酔および喉頭マスクは、非侵襲的人工呼吸器や気道陽圧装置の患者用インターフェースとして、病院、在宅環境、介護施設で一般的に使用されています。これらのマスクは、機器メーカーやサードパーティのサプライヤーから入手できます。さまざまなインターフェースの選択は、換気の有効性と患者の換気に対する耐性によって決まります。

当レポートは、世界の麻酔および喉頭マスク市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている麻酔および喉頭マスクと競合情勢

• 主要な業界動向の洞察
• 麻酔および喉頭マスクのセグメント別総市場収益と2015年～2033年の市場展望
• セグメント別の手技総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 麻酔および喉頭マスク市場のSWOT分析
• 麻酔および喉頭マスク市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Anesthesia and Laryngeal Masks Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Anesthesia and Laryngeal Masks market for the year 2020 and beyond. The large geriatric population base, suffering from respiratory diseases such as COPD, is the primary driver of the market. The United Nations estimates that the population of individuals of ages over 60 will reach two billion in 2050 with a growth rate of about 3% annually, considerably faster than the population as a whole (UNDESA, 2017). Population aging affects health and healthcare, and medical devices are a crucial component of healthcare delivery.

In addition, the global population with COPD continues to expand due to smoking and poor air quality. More than 200 million people worldwide are estimated to have COPD, including more than 65 million moderate-to-severe COPD patients (Ferkol and Schraufnagel, 2014). COPD is the third leading cause of death globally (World Health Organization, 2014). Anesthesia and Laryngeal Masks are highly involved with the therapeutic areas for acute and chronic respiratory diseases. A study showed that mortality risk reduced by over 60% on a relative basis using long-term non-invasive ventilation for COPD patients (Kohnlein et al., 2014). patients also experienced an improvement in quality of life and exercise capacity.

The rising number of COPD patients results in an increase in the size of the acute care hospitals market and the home care market. Anesthesia and Laryngeal Masks are commonly used in hospitals, home settings, and long-term care facilities, as patient interfaces for non-invasive ventilators or positive airway pressure devices. They are available from device manufacturers and third party suppliers. The choice of different interfaces depends on ventilation efficacy and the patient's tolerance of the ventilation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Anesthesia and Laryngeal Masks and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Anesthesia and Laryngeal Masks market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Anesthesia and Laryngeal Masks market.
• Competitive dynamics insights and trends provided for Anesthesia and Laryngeal Masks market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Teleflex Inc, Intersurgical Ltd., Medline Industries Inc, Ambu A/S, Medtronic Plc, Vyaire Medical Inc, ICU Medical Inc, Flexicare Group Ltd, Draegerwerk AG & Co KGaA, Jiangsu Weikang Jiejing Medical Apparatus Co Ltd, Cardinal Health Inc, Vygon SA and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Anesthesia and Laryngeal Masks marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Anesthesia & Laryngeal Masks market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Anesthesia & Laryngeal Masks market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Anesthesia & Laryngeal Masks market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Anesthesia & Laryngeal Masks market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable